|
Antibiotics Clinical Trials
1 actively recruiting trial
Also known as: Rifaximin
Pipeline
Phase 2: 1
Top Sponsors
- Soroka University Medical Center1
Indications
- Metastatic Lung Cancer1
- Lung Cancer1
- Cancer1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.